Revival of the regulatory T cell: new targets for drug development

Drug Discovery Today - Tập 9 - Trang 310-316 - 2004
Roger P.M Sutmuller, Rienk Offringa, Cornelis J.M Melief

Tài liệu tham khảo

Hoffmann, 1995, Deletion of high-avidity T cells by thymic epithelium, Proc. Natl. Acad. Sci. U. S. A., 92, 9851, 10.1073/pnas.92.21.9851 Viret, 1999, MHC and T cell development, Rev. Immunogenet., 1, 91 Chambers, 1997, Co-stimulation in T cell responses, Curr. Opin. Immunol., 9, 396, 10.1016/S0952-7915(97)80087-8 Melief, 2000, Strategies for immunotherapy of cancer, Adv. Immunol., 75, 235, 10.1016/S0065-2776(00)75006-1 Janssen, 2000, Regulation of activation-induced cell death of mature T-lymphocyte populations, Cell Tissue Res., 301, 85, 10.1007/s004419900155 Nguyen, 2001, The regulation of FasL expression during activation-induced cell death (AICD), Immunology, 103, 426, 10.1046/j.1365-2567.2001.01264.x Conroy, 1996, The role of intracellular signaling pathways regulating thymocyte and leukemic T cell apoptosis, Leukemia, 10, 1422 Oberg, 1997, Activation-induced T cell death: resistance or susceptibility correlate with cell surface fas ligand expression and T helper phenotype, Cell. Immunol., 181, 93, 10.1006/cimm.1997.1200 Oberg, 1997, Ligation of cell surface CD4 inhibits activation-induced death of human T lymphocytes at the level of Fas ligand expression, J. Immunol., 159, 5742, 10.4049/jimmunol.159.11.5742 Lee, 1998, Molecular basis of T cell inactivation by CTLA-4, Science, 282, 2263, 10.1126/science.282.5397.2263 Wells, 2001, Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy, J. Clin. Invest., 108, 895, 10.1172/JCI13220 Chambers, 1999, Co-stimulatory regulation of T cell function, Curr. Opin. Cell Biol., 11, 203, 10.1016/S0955-0674(99)80027-1 Zhai, 2001, T cell subsets and in vitro immune regulation in “infectious” transplantation tolerance, J. Immunol., 167, 4814, 10.4049/jimmunol.167.9.4814 Gershon, 1970, Cell interactions in the induction of tolerance: the role of thymic lymphocytes, Immunology, 18, 723 Green, 1993, Saying the’S’ word in public, Immunol. Today, 14, 523, 10.1016/0167-5699(93)90180-S Sakaguchi, 1995, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J. Immunol., 155, 1151, 10.4049/jimmunol.155.3.1151 Shevach, 2001, Control of T-cell activation by CD4+ CD25+ suppressor T cells, Immunol. Rev., 182, 58, 10.1034/j.1600-065X.2001.1820104.x Sakaguchi, 2001, Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance, Immunol. Rev., 182, 18, 10.1034/j.1600-065X.2001.1820102.x Takahashi, 1998, Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state, Int. Immunol., 10, 1969, 10.1093/intimm/10.12.1969 Suri-Payer, 1998, CD4+CD25+ T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells, J. Immunol., 160, 1212, 10.4049/jimmunol.160.3.1212 Piccirillo, 2001, Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells, J. Immunol., 167, 1137, 10.4049/jimmunol.167.3.1137 Thornton, 2000, Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific, J. Immunol., 164, 183, 10.4049/jimmunol.164.1.183 Itoh, 1999, Thymus and autoimmunity: production of CD25+CD4+ naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance, J. Immunol., 162, 5317, 10.4049/jimmunol.162.9.5317 Shevach, 2000, Regulatory T cells in autoimmmunity*, Annu. Rev. Immunol., 18, 423, 10.1146/annurev.immunol.18.1.423 Morgan, 2003, CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis, Arthritis Rheum., 48, 1452, 10.1002/art.11063 Azuma, 2003, Human CD4+ CD25+ regulatory T cells suppress NKT cell functions, Cancer Res., 63, 4516 Fisson, 2003, Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state, J. Exp. Med., 198, 737, 10.1084/jem.20030686 Lehmann, 2002, Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25− regulatory T cells, Proc. Natl. Acad. Sci. U. S. A., 99, 13031, 10.1073/pnas.192162899 Nakamura, 2001, Cell contact-dependent immunosuppression by CD4+CD25+ regulatory T cells is mediated by cell surface-bound transforming growth factor beta, J. Exp. Med., 194, 629, 10.1084/jem.194.5.629 Groux, 1997, A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature, 389, 737, 10.1038/39614 Moore, 2001, Interleukin-10 and the interleukin-10 receptor, Annu. Rev. Immunol., 19, 683, 10.1146/annurev.immunol.19.1.683 Weiner, 2001, Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells, Microbes Infect., 3, 947, 10.1016/S1286-4579(01)01456-3 Weiner, 2001, Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells, Immunol. Rev., 182, 207, 10.1034/j.1600-065X.2001.1820117.x Jonuleit, 2000, Induction of interleukin 10-producing, nonproliferating CD4+ T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells, J. Exp. Med., 192, 1213, 10.1084/jem.192.9.1213 Yamagiwa, 2001, A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood, J. Immunol., 166, 7282, 10.4049/jimmunol.166.12.7282 Taams, 2000, ‘Anergic’ T cells modulate the T-cell activating capacity of antigen-presenting cells, J. Autoimmun., 14, 335, 10.1006/jaut.2000.0372 Vendetti, 2000, Anergic T cells inhibit the antigen-presenting function of dendritic cells, J. Immunol., 165, 1175, 10.4049/jimmunol.165.3.1175 Jiang, 1998, Induction of MHC-class I restricted human suppressor T cells by peptide priming in vitro, Hum. Immunol., 59, 690, 10.1016/S0198-8859(98)00073-1 Ciubotariu, 2001, Detection of T suppressor cells in patients with organ allografts, Hum. Immunol., 62, 15, 10.1016/S0198-8859(00)00226-3 Chang, 2002, Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4, Nat. Immunol., 3, 237, 10.1038/ni760 Zhang, 2000, Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression, Nat. Med., 6, 782, 10.1038/77513 Zhang, 2002, Ly-6A is critical for the function of double negative regulatory T cells, Eur. J. Immunol., 32, 1584, 10.1002/1521-4141(200206)32:6<1584::AID-IMMU1584>3.0.CO;2-2 Romagnoli, 2002, Preferential recognition of self-antigens despite normal thymic deletion of CD4+CD25+ regulatory T cells, J. Immunol., 168, 1644, 10.4049/jimmunol.168.4.1644 Pacholczyk, 2002, Peptide specificity of thymic selection of CD4+CD25+ T cells, J. Immunol., 168, 613, 10.4049/jimmunol.168.2.613 Jordan, 2001, Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide, Nat. Immunol., 2, 301, 10.1038/86302 Kawahata, 2002, Generation of CD4+CD25+ regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression, J. Immunol., 168, 4399, 10.4049/jimmunol.168.9.4399 Jordan, 2000, Anergy and suppression regulate CD4+ T cell responses to a self-peptide, Eur. J. Immunol., 30, 136, 10.1002/1521-4141(200001)30:1<136::AID-IMMU136>3.0.CO;2-0 Levings, 2001, Human cd25+cd4+ t regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function, J. Exp. Med., 193, 1295, 10.1084/jem.193.11.1295 Ermann, 2001, CD4+CD25+ T cells facilitate the induction of T cell anergy, J. Immunol., 167, 4271, 10.4049/jimmunol.167.8.4271 Cederbom, 2000, CD4+CD25+ regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells, Eur. J. Immunol., 30, 1538, 10.1002/1521-4141(200006)30:6<1538::AID-IMMU1538>3.0.CO;2-X Shimizu, 2002, Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance, Nat. Immunol., 3, 135, 10.1038/ni759 McHugh, 2002, CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor, Immunity, 16, 311, 10.1016/S1074-7613(02)00280-7 Tone, 2003, Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is co-stimulatory for T cells, Proc. Natl. Acad. Sci. U. S. A., 100, 15059, 10.1073/pnas.2334901100 Thompson, 1997, The emerging role of CTLA-4 as an immune attenuator, Immunity, 7, 445, 10.1016/S1074-7613(00)80366-0 Chambers, 1996, The role of CTLA-4 in the regulation and initiation of T-cell responses, Immunol. Rev., 153, 27, 10.1111/j.1600-065X.1996.tb00919.x Sutmuller, 2001, Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses, J. Exp. Med., 194, 823, 10.1084/jem.194.6.823 Read, 2000, Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation, J. Exp. Med., 192, 295, 10.1084/jem.192.2.295 Zhang, 2001, Activation of CD25+CD4+ regulatory T cells by oral antigen administration, J. Immunol., 167, 4245, 10.4049/jimmunol.167.8.4245 Takahashi, 2000, Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4, J. Exp. Med., 192, 303, 10.1084/jem.192.2.303 Kingsley, 2002, CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses, J. Immunol., 168, 1080, 10.4049/jimmunol.168.3.1080 Sanchez-Fueyo, 2002, Tracking the immunoregulatory mechanisms active during allograft tolerance, J. Immunol., 168, 2274, 10.4049/jimmunol.168.5.2274 Baecher-Allan, 2001, CD4+CD25 high regulatory cells in human peripheral blood, J. Immunol., 167, 1245, 10.4049/jimmunol.167.3.1245 Jonuleit, 2002, Infectious tolerance: human CD25+ regulatory T cells convey suppressor activity to conventional CD4+ T helper cells, J. Exp. Med., 196, 255, 10.1084/jem.20020394 Shevach, 2002, CD4+ CD25+ suppressor T cells: more questions than answers, Nat. Rev. Immunol., 2, 389, 10.1038/nri821 Chiffoleau, 2002, Role for thymic and splenic regulatory CD4+ T Cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment, J. Immunol., 168, 5058, 10.4049/jimmunol.168.10.5058 Graca, 2002, Identification of regulatory T cells in tolerated allografts, J. Exp. Med., 195, 1641, 10.1084/jem.20012097 Koenen, 2000, Blockade of CD86 and CD40 induces alloantigen-specific immunoregulatory T cells that remain anergic even after reversal of hyporesponsiveness, Blood, 95, 3153, 10.1182/blood.V95.10.3153 Shimizu, 1999, Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity, J. Immunol., 163, 5211, 10.4049/jimmunol.163.10.5211 Onizuka, 1999, Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody, Cancer Res., 59, 3128 Hori, 2003, Control of regulatory T cell development by the transcription factor Foxp3, Science, 299, 1057, 10.1126/science.1079490 Matsue, 2002, Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell–T cell interaction during antigen presentation, J. Immunol., 169, 3555, 10.4049/jimmunol.169.7.3555 Rea, 2000, Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10, Blood, 95, 3162, 10.1182/blood.V95.10.3162 Akira, 2003, Recognition of pathogen-associated molecular patterns by TLR family, Immunol. Lett., 85, 85, 10.1016/S0165-2478(02)00228-6 Caramalho, 2003, Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide, J. Exp. Med., 197, 403, 10.1084/jem.20021633